scholarly journals Near Real-Time Intraoperative Brain Tumor Diagnosis Using Stimulated Raman Histology and Deep Neural Networks

Neurosurgery ◽  
2019 ◽  
Vol 66 (Supplement_1) ◽  
Author(s):  
Todd C Hollon ◽  
Balaji Pandian ◽  
Siri Sahib Singh Khalsa ◽  
Randy D’Amico ◽  
Michael B Sisti ◽  
...  

Abstract INTRODUCTION Intraoperative diagnosis is essential for providing safe and effective care during cancer surgery. The existing workflow for intraoperative diagnosis based on H&E staining of processed tissue is time-, resource-, and labor-intensive. Moreover, interpretation of intraoperative histologic images is dependent on a pathology workforce that is contracting and unevenly distributed across the centers where cancer surgery is performed worldwide. METHODS We developed an automated workflow, independent of traditional H&E histology, that combines stimulated Raman histology (SRH), a rapid label-free optical imaging method, and deep convolutional neural networks (CNN) to predict diagnosis at the bedside in near real time. Specifically, our CNN, trained on over 2.5 million SRH images, predicts brain tumor diagnosis in the operating room in under 150 s, which is an order of magnitude faster than conventional techniques (eg, 20-30 min). RESULTS To validate our workflow in the clinical setting, we designed a multicenter, prospective, noninferiority clinical trial (N = 204) that compares SRH plus CNN vs traditional H&E histology. Primary endpoint was overall diagnostic accuracy. We show that CNN-based diagnosis of SRH images was noninferior to pathologist-based interpretation of conventional histologic images (overall accuracy, 94.6% vs 95.5%). Additionally, our CNN learned a hierarchy of interpretable histologic feature representations to classify the major histopathologic classes of brain tumors. We then developed and implemented a semantic segmentation method that can identify tumor infiltrated and diagnostic regions within SRH images. Mean intersection over union values was 61 ± 28.6 for ground truth diagnostic class and 86.0 ± 28.6 for tumor-infiltrated regions. CONCLUSION We have demonstrated how combining bedside optical histology with deep learning can result in near real-time intraoperative brain tumor diagnosis. Our workflow provides a means of delivering expert-level intraoperative diagnosis where neuropathology resources are scarce and improve diagnostic accuracy in resource-rich centers.

2020 ◽  
Vol 26 (1) ◽  
pp. 52-58 ◽  
Author(s):  
Todd C. Hollon ◽  
Balaji Pandian ◽  
Arjun R. Adapa ◽  
Esteban Urias ◽  
Akshay V. Save ◽  
...  

Author(s):  
Yoshihiro Tanaka ◽  
Qingyun Yu ◽  
Kazuki Doumoto ◽  
Akihito Sano ◽  
Yuichiro Hayashi ◽  
...  

1999 ◽  
Vol 21 (1) ◽  
pp. 121-124 ◽  
Author(s):  
J. Slowiński ◽  
M. Harabin-Slowińska ◽  
R. Mrówka

2021 ◽  
Author(s):  
Luka Vranić ◽  
Tin Nadarević ◽  
Davor Štimac

Background: Barrett’s esophagus (BE) requires surveillance to identify potential neoplasia at early stage. Standard surveillance regimen includes random four-quadrant biopsies by Seattle protocol. Main limitations of random biopsies are high risk of sampling error, difficulties in histology interpretation, common inadequate classification of pathohistological changes, increased risk of bleeding and time necessary to acquire the final diagnosis. Probe-based confocal laser endomicroscopy (pCLE) has emerged as a potential tool with an aim to overcome these obvious limitations. Summary: pCLE represents real-time microscopic imaging method that offers evaluation of epithelial and subepithelial structures with 1000-fold magnification. In theory, pCLE has potential to eliminate the need for biopsy in BE patient. The main advantages would be real-time diagnosis and decision making, greater diagnostic accuracy and to evaluate larger area compared to random biopsies. Clinical pCLE studies in esophagus show high diagnostic accuracy and its high negative predictive value offers high reliability and confidence to exclude dysplastic and neoplastic lesions. However, it still cannot replace histopathology due to lower positive predictive value and sensitivity. Key messages: Despite promising results, its role in routine use in patients with Barrett’s esophagus remains questionable primarily due to lack of well-organized double-blind randomized trials.


2017 ◽  
Vol 09 (01) ◽  
Author(s):  
Hamidreza Shirzadfar ◽  
Samin Riahi ◽  
Mahsa Sadat Ghaziasgar

Sign in / Sign up

Export Citation Format

Share Document